H Quiros Ambel on Muck Rack

H Quiros Ambel

As seen in: European Journal of Hospital Pharmacy
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with H Quiros

Contact H Quiros, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

CP-214 Apremilast: assesing the value in psoriasis and psoriatic arthritis patients

|
By JM Martinez-Sesmero, FJ Manzano Lista, A Gonzalez Cantero, H Quiros Ambel
| European Journal of Hospital Pharmacy Verified
Background Apremilast is the first oral selective inhibitor of phosphodiesterase 4 (PDE4) indicated for adults with active psoriatic arthritis (PsA) and moderate to severe plaque psoriasis (Pso). Pso and PsA are chronic disorders with significant morbidity, and patients experience diminished health related quality of life (QoL). Purpose The primary objective was to assess changes in QoL and satisfaction of patients starting treatment with apremilast.
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified